Peroxisome Proliferator-activated Receptor (PPAR) Agonists with 3,4-Dihydro-2H-benzo[e][1,3]oxazine and 2,3,4,5-Tetrahydrobenzo[f][1,4]oxazepine Skeletons: Effects of Cyclization of Linker Moiety on PPAR-Agonistic Activity
Peroxisome Proliferator-activated Receptor (PPAR) Agonists with 3,4-Dihydro-2H-benzo[e][1,3]oxazine and 2,3,4,5-Tetrahydrobenzo[f][1,4]oxazepine Skeletons: Effects of Cyclization of Linker Moiety on PPAR-Agonistic Activity